
Dr Kathi Mooney Discusses Improving Patients' Quality of Life Through Technology
Kathi Mooney, PhD, RN, FAAN, of the University of Utah, discussed technologies she and her team developed to help improve the quality of life of patients with cancer and their families.
At the University of Utah, Mooney is a distinguished professor within the College of Nursing and
Transcript
What technologies have you and your team developed to improve the quality of life for cancer patients and their families?
We have been interested in how to decrease symptom burden in cancer patients for now over 20 years. We started with the idea that one of the issues is communication between patients and their providers about their symptoms, and how we found, in patients, even though we provide them self-management booklets, and they may have a chemotherapy class, that, in spite of that, they still have difficulty at home in achieving symptom management. My concern was that we aren't very good at monitoring patients at home.
So, our initial research looked at developing a patient-reported symptom platform called "Symptom Care at Home," where patients on a daily basis, when they were at home, reported their symptoms and then received automated self-management coaching just in time around the symptoms they were actually experiencing at the severity levels they were experiencing. This helped improve on how we do it. Now, rather than giving patients a bunch of information when they have no symptoms that then they're supposed to refer to when they do is to actually provide symptom information at the time their experiencing symptoms.
So, that was an automated system. Then, we had alert functions put in. So, symptoms that were at moderate or severe levels would trigger an alert to a nurse practitioner who would respond to the patient to see if adjustments in their care were needed in order to bring the symptoms down so that they didn't proceed to an acute episode.
What outcomes have you observed when implementing these interventions in real-world settings?
In terms of Symptom Care at Home, we found that it decreased severe symptom days by two-thirds, moderate symptom days by 40%, and increased mild symptom days and no symptom days. So, it really reversed the experience that patients have now with usual care in terms of the number of days that they are experiencing significant symptom burden. It also decreased the use of emergency departments and rehospitalization. So, it really was very effective in helping patients manage symptoms at home.
In terms of the Huntsman at Home program that
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.